Fabior FDA Approval History
FDA Approved: Yes (First approved May 11, 2012)
Brand name: Fabior
Generic name: tazarotene
Dosage form: Foam
Company: Stiefel Laboratories, Inc.
Treatment for: Acne
Fabior (tazarotene) Foam is a retinoid indicated for the topical treatment of acne vulgaris.
Development Timeline for Fabior
|May 14, 2012||Stiefel Receives US FDA Approval of Fabior Foam, 0.1%|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.